ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.